Roger Humphrey

Roger Humphrey is executive managing director of JLL Life Sciences.

Articles by Roger Humphrey

Labs on the Frontlines: Balancing Re-Entry and the Race to a COVID-19 Cure

August 31st 2020

How real estate can accelerate productivity as life sciences companies prioritize COVID-19 therapeutics, vaccines, and new diagnostics R&D amidst new guidelines.

Emerging Life-Sciences Markets: New Partnerships, New Competitors

ByRoger Humphrey

February 1st 2016

Aging populations and increased access to healthcare translates into opportunities for biopharmaceutical companies.

Latest Updated Articles

Labs on the Frontlines: Balancing Re-Entry and the Race to a COVID-19 Cure
August 31st 2020
Emerging Life-Sciences Markets: New Partnerships, New Competitors
February 1st 2016

Roger Humphrey

Articles by Roger Humphrey

Labs on the Frontlines: Balancing Re-Entry and the Race to a COVID-19 Cure

Emerging Life-Sciences Markets: New Partnerships, New Competitors

Latest Updated Articles

Trending on Pharmaceutical Technology

Viral Safety 2.0: Plant-Ready Actions for ICH Q5A(R2) Compliance

FDA Guidance for Accelerating Gene Therapies for Rare Diseases

Implications of Pediatric Inhaled Insulin Approval

Generic GLP-1s Enter Canadian Market

Leveraging an Innovative Mid-Scale Manufacturing Solution to Meet Diverse Needs